Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chiara Nardoni
Observed names:
C Nardoni,
C. Nardoni
Institution:
Instituto Nazionale Tumori Regina Elena
Observed institutions:
Ospedale di Belcolle,
Instituto Nazionale Tumori Regina Elena
OpenAlex ID:
A5078833999
A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease
2006
·
P. Papaldo
, A. Fabi
, et al.
·
Annals of Oncology
·
86
PDF
Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer
2003
·
M. Zeuli
, C. Nardoni
, et al.
·
Annals of Oncology
·
63
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study
2010
·
Antonio Rozzi
, Chiara Nardoni
, et al.
·
Supportive Care in Cancer
·
20
Pegylated liposomal doxorubicin as third-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study
2013
·
Antonio Rozzi
, Daniele Santini
, et al.
·
Medical Oncology
·
18
A feasibility study of gefitinib in association with capecitabine (CAP) and oxaliplatin (OXA) as first-line treatment in patients with advanced colorectal cancer (ACRC)
2004
·
M. Zeuli
, A. Gelibter
, et al.
·
Journal of Clinical Oncology
·
17
Weekly Regimen of Paclitaxel and Carboplatin as First-Line Chemotherapy in Elderly Patients with Stage IIIB-IV Non Small Cell Lung Cancer (NSCLC): Results of a Phase II Study
2010
·
A. Rozzi
, C. Nardoni
, et al.
·
Journal of Chemotherapy
·
16
Nail disorders in a woman treated with ixabepilone for metastatic breast cancer.
2005
·
Andrea Alimonti
, Chiara Nardoni
, et al.
·
PubMed
·
9
Epirubicin plus docetaxel in metastatic breast cancer: escalating dose does not improve efficacy. A phase II study.
2004
·
Alessandra Fabi
, Paola Papaldo
, et al.
·
PubMed
·
9
Does the concurrent use of anthracycline and granulocyte colony-stimulating factor influence the risk of secondary leukaemia in breast cancer women?
2005
·
S. Di Cosimo
, G. Ferretti
, et al.
·
Annals of Oncology
·
7
PDF
Ifosfamide and Epirubicin Combination in Untreated Sarcomas: Two Treatment Schedules
2001
·
L. Serrone
, M. Zeuli
, et al.
·
Oncology Research and Treatment
·
5
Can HER2 overexpression predict response to pegylated liposomal doxorubicin in metastatic breast cancer patients?
2005
·
A. Fabi
, G. Ferretti
, et al.
·
Annals of Oncology
·
4
Alfa-epoietin and anaemia in gynaecological cancer.
2004
·
Barbara Di Cocco
, Nello Salesi
, et al.
·
PubMed
·
1
7144 POSTER Weekly Paclitaxel as Third-line Chemotherapy in Patients With Metastatic Transitional Cell Carcinoma of Urothelial Tract: Results of a Phase II Study
2011
·
A. Rozzi
, C. Nardoni
, et al.
·
European Journal of Cancer
Topoisomerase II and chemosensitivity for pegylated liposomal doxorubicin (pld) used in the third-line treatment of patients with metastatic bladder cancer.
2011
·
A. Rozzi
, A. P. Mancuso
, et al.
·
Journal of Clinical Oncology
高齢進行性胃癌患者に対する第一選択化学療法としてのオキサリプラチン及びカペシタビン(xelox):一施設での経験の結果
2009
·
Antonio Rozzi
, M. Corona
, et al.
·
Annals of Oncology
Salvage chemotherapy for advanced sarcoma patients: a single-institution experience survey.
2002
·
L Serrone
, C Nardoni
, et al.
·
PubMed
Industrial Forum · Industrieforum
2001
·
G. Hartung
, R.-D. Hofheinz
, et al.
·
Oncology Research and Treatment
PDF
Oxaliplatin and capecitabine in advanced colorectal cancer: a pilot study
2001
·
M. Zeuli
, F. Di Costanzo
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
18
Citation count:
255
H-index:
8
I10-index:
6
Year
Topic
Type